Yüklüyor......
Tamoxifen Chemoprevention Treatment and Time to First Diagnosis of Estrogen Receptor–Negative Breast Cancer
BACKGROUND: Tamoxifen’s effect of reducing the risk of estrogen receptor (ER)–positive breast cancer is well established. Its effect on the time to first diagnosis of breast cancer has not been reported. We used information from the randomized, placebo-controlled Breast Cancer Prevention Trial (BCPT...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2720727/ https://ncbi.nlm.nih.gov/pubmed/18840821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn320 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|